Cargando…
Molecular Characterization of Prothionamide-Resistant Mycobacterium tuberculosis Isolates in Southern China
Prothionamide (PTH) has been widely used in the treatment of tuberculosis (TB), especially multidrug resistant tuberculosis (MDR-TB), while data regarding prevalence of resistance-causing mutation is limited. In this study, we aimed to investigate the molecular characteristics of PTH-resistant MTB i...
Autores principales: | Tan, Yaoju, Su, Biyi, Zheng, Huiwen, Song, Yuanyuan, Wang, Yufeng, Pang, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714880/ https://www.ncbi.nlm.nih.gov/pubmed/29250048 http://dx.doi.org/10.3389/fmicb.2017.02358 |
Ejemplares similares
-
Effect of Mixed Infections with Mycobacterium tuberculosis and Nontuberculous Mycobacteria on Diagnosis of Multidrug-Resistant Tuberculosis: A Retrospective Multicentre Study in China
por: Huang, Mingxiang, et al.
Publicado: (2022) -
Mutation EthA(W21R) confers co-resistance to prothionamide and ethionamide in both Mycobacterium bovis BCG and Mycobacterium tuberculosis H37Rv
por: Mugweru, Julius, et al.
Publicado: (2018) -
Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China
por: Pang, Yu, et al.
Publicado: (2017) -
Acute interstitial nephritis with Prothionamide
por: Asnake, Molla, et al.
Publicado: (2022) -
Bacterial Genome-Wide Association Identifies Novel Factors That Contribute to Ethionamide and Prothionamide Susceptibility in Mycobacterium tuberculosis
por: Hicks, Nathan D., et al.
Publicado: (2019)